AU775713B2 - Potassium channel interactors and uses therefor - Google Patents

Potassium channel interactors and uses therefor Download PDF

Info

Publication number
AU775713B2
AU775713B2 AU14797/00A AU1479700A AU775713B2 AU 775713 B2 AU775713 B2 AU 775713B2 AU 14797/00 A AU14797/00 A AU 14797/00A AU 1479700 A AU1479700 A AU 1479700A AU 775713 B2 AU775713 B2 AU 775713B2
Authority
AU
Australia
Prior art keywords
seq
pcip
nucleic acid
polypeptide
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU14797/00A
Other languages
English (en)
Other versions
AU1479700A (en
Inventor
Wenqian An
Maria Betty
Huai-Ping Ling
Kenneth Rhodes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/298,731 external-priority patent/US6369197B1/en
Priority claimed from US09/350,874 external-priority patent/US20020019020A1/en
Priority claimed from US09/399,913 external-priority patent/US6361971B1/en
Priority claimed from US09/400,492 external-priority patent/US7115381B1/en
Application filed by Millennium Pharmaceuticals Inc, American Home Products Corp filed Critical Millennium Pharmaceuticals Inc
Publication of AU1479700A publication Critical patent/AU1479700A/en
Application granted granted Critical
Publication of AU775713B2 publication Critical patent/AU775713B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU14797/00A 1998-11-20 1999-11-19 Potassium channel interactors and uses therefor Ceased AU775713B2 (en)

Applications Claiming Priority (17)

Application Number Priority Date Filing Date Title
US10933398P 1998-11-20 1998-11-20
US60/109333 1998-11-20
US11003398P 1998-11-25 1998-11-25
US60/110033 1998-11-25
US11027798P 1998-11-30 1998-11-30
US60/110277 1998-11-30
US09/298731 1999-04-23
US09/298,731 US6369197B1 (en) 1998-11-20 1999-04-23 Potassium channel interactors and uses therefor
US09/350,874 US20020019020A1 (en) 1998-11-20 1999-07-09 Methods for treating cardiovascular disorders
US09/350874 1999-07-09
US09/350614 1999-07-09
US09/350,614 US6689581B1 (en) 1998-11-20 1999-07-09 Potassium channel interactors and uses therefor
US09/399,913 US6361971B1 (en) 1998-11-20 1999-09-21 Nucleic acid molecules encoding potassium channel interactors and uses therefor
US09/400492 1999-09-21
US09/400,492 US7115381B1 (en) 1998-11-20 1999-09-21 Methods for treating cardiovascular disorders
US09/399913 1999-09-21
PCT/US1999/027428 WO2000031133A2 (en) 1998-11-20 1999-11-19 Potassium channel interactors and uses therefor

Publications (2)

Publication Number Publication Date
AU1479700A AU1479700A (en) 2000-06-13
AU775713B2 true AU775713B2 (en) 2004-08-12

Family

ID=27574798

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14797/00A Ceased AU775713B2 (en) 1998-11-20 1999-11-19 Potassium channel interactors and uses therefor

Country Status (12)

Country Link
EP (1) EP1131349A2 (es)
JP (1) JP2002530104A (es)
CN (1) CN1346368A (es)
AU (1) AU775713B2 (es)
BR (1) BR9915513A (es)
CA (1) CA2351365A1 (es)
CZ (1) CZ20011764A3 (es)
IL (1) IL143148A0 (es)
MX (1) MXPA01004903A (es)
NO (1) NO20012471L (es)
NZ (1) NZ512332A (es)
WO (1) WO2000031133A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6369197B1 (en) 1998-11-20 2002-04-09 Millennium Pharmaceuticals, Inc. Potassium channel interactors and uses therefor
US7078481B1 (en) 1998-11-20 2006-07-18 Wyeth Potassium channel interactors and uses therefor
EA200300420A1 (ru) * 2000-09-27 2004-04-29 Милленниум Фамэсьютикэлс, Инк. Выделенная молекула нуклеиновой кислоты, выделенный полипептид и способ его получения, способ обнаружения их присутствия в образце (варианты), клетка-хозяин (варианты), антитело, набор (варианты), способ модулирования активности полипептида, способ идентификации (варианты) и применение соединения, способ выявления субъекта (варианты) и способ лечения субъекта с нарушением, связанным с калиевыми каналами (варианты)
JP2012507273A (ja) * 2008-11-06 2012-03-29 ビーエーエスエフ ソシエタス・ヨーロピア 殺虫剤のスクリーニングアッセイ
GB201906482D0 (en) * 2019-05-08 2019-06-19 Evox Therapeutics Ltd Exosome comprising stabilized RNA therapeutics

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4758997A (en) * 1996-10-17 1998-05-11 Nps Pharmaceuticals, Inc. Potassium channel blocking compounds and their use
US6117989A (en) * 1998-03-26 2000-09-12 Incyte Pharmaceuticals, Inc. Human calcium-binding proteins

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL (ONLINE) ID:A 1038858, 1 JULY 1998 *
NATURE MEDICINE, VOL.4 NO.10, OCTOBER 1998, PP 1177-1181 *

Also Published As

Publication number Publication date
CN1346368A (zh) 2002-04-24
AU1479700A (en) 2000-06-13
CA2351365A1 (en) 2000-06-02
NO20012471D0 (no) 2001-05-18
WO2000031133A3 (en) 2000-10-05
MXPA01004903A (es) 2003-03-10
JP2002530104A (ja) 2002-09-17
BR9915513A (pt) 2002-02-05
WO2000031133A2 (en) 2000-06-02
NZ512332A (en) 2004-02-27
NO20012471L (no) 2001-07-18
CZ20011764A3 (cs) 2002-01-16
IL143148A0 (en) 2002-04-21
EP1131349A2 (en) 2001-09-12

Similar Documents

Publication Publication Date Title
US20020168708A1 (en) Muscarinic receptors and uses therefor
US20030232378A1 (en) Novel toll molecules and uses therefor
US6780987B1 (en) β-cap73 control of normal and abnormal cell migration
US6518398B1 (en) ERG potassium channel
JP2004507215A (ja) 新規のｐ−セレクチン糖タンパク質リガンド（ｐｓｇｌ−１）結合タンパク質およびその使用
AU775713B2 (en) Potassium channel interactors and uses therefor
US6225085B1 (en) LRSG protein and nucleic acid molecules and uses therefor
US6361971B1 (en) Nucleic acid molecules encoding potassium channel interactors and uses therefor
US6689581B1 (en) Potassium channel interactors and uses therefor
US20020197680A1 (en) 54420, a novel human calcium channel
AU2001296393A1 (en) Potassium channel interactors and uses therefor
US20020081658A1 (en) 18610, a novel human transient receptor and uses thereof
US7078481B1 (en) Potassium channel interactors and uses therefor
US6756212B1 (en) Isolated proteins and nucleic acid molecules having homology to the NIP2 protein and uses thereof
US20020034781A1 (en) 12303, a novel human TWIK molecule and uses thereof
US7439029B2 (en) Human 9q polypeptides method
US20020081651A1 (en) 26649, a novel human GTPase activating molecule and uses therefor
WO2000043514A9 (en) Human acid sensing ion channel and uses thereof
US20020019020A1 (en) Methods for treating cardiovascular disorders
ZA200103995B (en) Potassium channel interactors and uses therefor.
US20030049727A1 (en) 25658, a novel human calcium channel subunit and uses thereof
WO2001081416A2 (en) Human ion channel and uses thereof